טוען...
Engineering Synthetically Modified Insulin for Glucose-Responsive Diabetes Therapy
Though a suite of different insulin variants have been used clinically to provide greater control over pharmacokinetics, no clinically used insulin can tune its potency and/or bioavailability in a glucose-dependent manner. In order to improve therapy for diabetic patients, a vision has been the deve...
שמור ב:
| הוצא לאור ב: | Expert Rev Endocrinol Metab |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4999256/ https://ncbi.nlm.nih.gov/pubmed/27570535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/17446651.2015.1071187 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|